SNMMI Press Releases
March 18, 2011
New Editor-in-Chief Selected for The Journal of Nuclear Medicine
Reston, Va. — Dominique Delbeke, MD, PhD, has been named as the next editor-in-chief for The Journal of Nuclear Medicine (JNM). Her appointment for the 2012-2016 term was confirmed by the SNM House of Delegates at the society’s Mid-Winter Meeting in January.
Delbeke is professor and director of nuclear medicine and positron emission tomography in the Department of Radiology and Radiological Sciences at Vanderbilt University in Nashville, Tenn. She also serves as a consultant to the Veteran Administration of the Tennessee Valley. Delbeke has published more than 120 peer-reviewed journal articles and is the author of five books and nearly 70 book chapters.
“JNM is the educational flagship of SNM, disseminating research to members of SNM and the medical community at large to advance the field of nuclear medicine and molecular imaging,” said Delbeke. She is committed to maintaining the quality and timeliness of the review process and conducting outreach for national and international visibility of JNM.
Prior to assuming the editor-in-chief position, Delbeke will work with current editor-in-chief, Heinrich Schelbert, MD, PhD, during a transition period that will begin in July 2011. Delbeke will identify associate and consulting editors for JNM during this time.
“Dominique has a passion for the field of nuclear medicine and molecular imaging and has contributed greatly to the community over the years,” said Schelbert, who has served as editor-in-chief since 2004. “Her expertise and leadership will undoubtedly benefit JNM and its readers.
For more than 40 years, JNM has brought readers from around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities and updates on rapidly changing issues in practice and research. JNM has the highest impact factor—6.424—of any medical imaging or radiology journal worldwide.
About SNM—Advancing Molecular Imaging and Therapy
SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.
SNM’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snm.org.